Literature DB >> 34211088

TRIM44 mediated p62 deubiquitination enhances DNA damage repair by increasing nuclear FLNA and 53BP1 expression.

Lin Lyu1, Tsung-Chin Lin1, Nami McCarty2.   

Abstract

Cancer cells show increases in protein degradation pathways, including autophagy, during progression to meet the increased protein degradation demand and support cell survival. On the other hand, reduced autophagy activity during aging is associated with a reduced DNA damage response and increased genomic instability. Therefore, it is a puzzling how DNA repair can be increased in cancer cells that are resistant to chemotherapies or during progression when autophagy activity is intact or increased. We discovered that tripartite motif containing 44 (TRIM44) is a pivotal element regulating the DNA damage response in cancer cells with intact autophagy. TRIM44 deubiquitinates p62, an autophagy substrate, which leads to its oligomerization. This prevents p62 localization to the nucleus upon irradiation. Increased cytoplasmic retention of p62 by TRIM44 prevents the degradation of FLNA and 53BP1, which increases DNA damage repair. Together, our data support TRIM44 a potential therapeutic target for therapy-resistant tumor cells with intact autophagy.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34211088     DOI: 10.1038/s41388-021-01890-7

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

Review 1.  DNA-damage response in tissue-specific and cancer stem cells.

Authors:  Cedric Blanpain; Mary Mohrin; Panagiota A Sotiropoulou; Emmanuelle Passegué
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

Review 2.  The DNA damage response: ten years after.

Authors:  J Wade Harper; Stephen J Elledge
Journal:  Mol Cell       Date:  2007-12-14       Impact factor: 17.970

3.  Multiple Myeloma: Diagnosis and Treatment.

Authors:  Thomas C Michels; Keith E Petersen
Journal:  Am Fam Physician       Date:  2017-03-15       Impact factor: 3.292

4.  Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX.

Authors:  D K Walters; X Wu; R C Tschumper; B K Arendt; P M Huddleston; K J Henderson; A Dispenzieri; D F Jelinek
Journal:  Leukemia       Date:  2011-05-13       Impact factor: 11.528

5.  Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.

Authors:  Masood A Shammas; Robert J Shmookler Reis; Hemanta Koley; Ramesh B Batchu; Cheng Li; Nikhil C Munshi
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

6.  Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome.

Authors:  S Boehrer; L Adès; N Tajeddine; W K Hofmann; S Kriener; G Bug; O G Ottmann; M Ruthardt; L Galluzzi; C Fouassier; M Tailler; K A Olaussen; C Gardin; V Eclache; S de Botton; S Thepot; P Fenaux; G Kroemer
Journal:  Oncogene       Date:  2009-04-27       Impact factor: 9.867

Review 7.  TRIM proteins in cancer.

Authors:  Valeria Cambiaghi; Virginia Giuliani; Sara Lombardi; Cristiano Marinelli; Francesca Toffalorio; Pier Giuseppe Pelicci
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 8.  New strategies in the treatment of multiple myeloma.

Authors:  Nikhil C Munshi; Kenneth C Anderson
Journal:  Clin Cancer Res       Date:  2013-03-20       Impact factor: 12.531

9.  Deregulation of DNA double-strand break repair in multiple myeloma: implications for genome stability.

Authors:  Ana B Herrero; Jesús San Miguel; Norma C Gutierrez
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

Review 10.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

View more
  4 in total

1.  TRIM44 promotes BRCA1 functions in HR repair to induce Cisplatin Chemoresistance in Lung Adenocarcinoma by Deubiquitinating FLNA.

Authors:  Shuai Zhang; Mengru Cao; Shi Yan; Yuechao Liu; Weina Fan; Yimeng Cui; Fanglin Tian; Ruixue Gu; Yaowen Cui; Yuning Zhan; Yuanyuan Sun; Ying Xing; Li Cai; Yang Song
Journal:  Int J Biol Sci       Date:  2022-04-18       Impact factor: 10.750

2.  Mechanism Study on Radiosensitization Effect of Curcumin in Bladder Cancer Cells Regulated by Filamin A.

Authors:  Zhenfan Wang; Shuqing He; Minjun Jiang; Xue Li; Na Chen
Journal:  Dose Response       Date:  2022-06-02       Impact factor: 2.623

3.  Sema3d Restrained Hepatocellular Carcinoma Progression Through Inactivating Pi3k/Akt Signaling via Interaction With FLNA.

Authors:  Yiming Li; Cong Xu; Bo Sun; Fangjing Zhong; Momo Cao; Lianyue Yang
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

4.  Cardiac-specific Trim44 knockout in rat attenuates isoproterenol-induced cardiac remodeling via inhibition of AKT/mTOR pathway.

Authors:  Xiao-Yu Jiang; Fei-Fei Guan; Jia-Xin Ma; Wei Dong; Xiao-Long Qi; Xu Zhang; Wei Chen; Shan Gao; Xiang Gao; Shuo Pan; Ji-Zheng Wang; Yuan-Wu Ma; Lian-Feng Zhang; Dan Lu
Journal:  Dis Model Mech       Date:  2022-08-18       Impact factor: 5.732

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.